These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 23642062)
21. Epiblast-derived stem cells in embryonic and adult tissues. De Miguel MP; Arnalich Montiel F; Lopez Iglesias P; Blazquez Martinez A; Nistal M Int J Dev Biol; 2009; 53(8-10):1529-40. PubMed ID: 19757397 [TBL] [Abstract][Full Text] [Related]
22. Induced pluripotent stem cells: a new technology to study human diseases. Vitale AM; Wolvetang E; Mackay-Sim A Int J Biochem Cell Biol; 2011 Jun; 43(6):843-6. PubMed ID: 21458591 [TBL] [Abstract][Full Text] [Related]
23. [Application of stem cell technology and nuclear transfer in animal models]. Prelle K; Zakhartchenko V; Wolf E Z Arztl Fortbild Qualitatssich; 2002 Jul; 96(6-7):434-40. PubMed ID: 12219498 [TBL] [Abstract][Full Text] [Related]
30. [Breakthrough in research on pluripotent stem cells and their application in medicine]. Valdimarsdóttir G; Richter A Laeknabladid; 2015 Dec; 101(12):581-6. PubMed ID: 26656400 [TBL] [Abstract][Full Text] [Related]
31. Rho-associated kinase inhibitors promote the cardiac differentiation of embryonic and induced pluripotent stem cells. Cheng YT; Yeih DF; Liang SM; Chien CY; Yu YL; Ko BS; Jan YJ; Kuo CC; Sung LY; Shyue SK; Chen MF; Yet SF; Wu KK; Liou JY Int J Cardiol; 2015 Dec; 201():441-8. PubMed ID: 26313863 [TBL] [Abstract][Full Text] [Related]
33. iPS cell technology in regenerative medicine. Lengner CJ Ann N Y Acad Sci; 2010 Mar; 1192():38-44. PubMed ID: 20392216 [TBL] [Abstract][Full Text] [Related]
34. Hematopoietic development from human induced pluripotent stem cells. Lengerke C; Grauer M; Niebuhr NI; Riedt T; Kanz L; Park IH; Daley GQ Ann N Y Acad Sci; 2009 Sep; 1176():219-27. PubMed ID: 19796250 [TBL] [Abstract][Full Text] [Related]
35. The challenges and promises of blood engineered from human pluripotent stem cells. Dravid GG; Crooks GM Adv Drug Deliv Rev; 2011 Apr; 63(4-5):331-41. PubMed ID: 21232565 [TBL] [Abstract][Full Text] [Related]
36. Origins of mammalian hematopoiesis: in vivo paradigms and in vitro models. Lensch MW; Daley GQ Curr Top Dev Biol; 2004; 60():127-96. PubMed ID: 15094298 [TBL] [Abstract][Full Text] [Related]
37. ES and iPS cell research for cardiovascular regeneration. Yamashita JK Exp Cell Res; 2010 Oct; 316(16):2555-9. PubMed ID: 20385126 [TBL] [Abstract][Full Text] [Related]
38. Induced pluripotent stem (iPS) cells offer a powerful new tool for the life sciences. Nakamura Y J Stem Cells Regen Med; 2010; 6(1):2-9. PubMed ID: 24693054 [TBL] [Abstract][Full Text] [Related]
39. Making gametes from pluripotent stem cells--a promising role for very small embryonic-like stem cells. Bhartiya D; Hinduja I; Patel H; Bhilawadikar R Reprod Biol Endocrinol; 2014 Nov; 12():114. PubMed ID: 25421462 [TBL] [Abstract][Full Text] [Related]
40. In vivo evaluation of putative hematopoietic stem cells derived from human pluripotent stem cells. Hexum MK; Tian X; Kaufman DS Methods Mol Biol; 2011; 767():433-47. PubMed ID: 21822894 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]